The content is available as a PDF (202.2 KB).
Footnotes
Disclosure
The patient presented in this manuscript has given written informed consent to publication of his case details.
These authors contributed equally
References
- 1.Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34:e212–3. doi: 10.1111/jdv.16387. [DOI] [PubMed] [Google Scholar]
- 2.Suchonwanit P, Leerunyakul K, Kositkuljorn C. Cutaneous manifestations in COVID-19: Lessons learned from current evidence. J Am Acad Dermatol. 2020;83:e57–60. doi: 10.1016/j.jaad.2020.04.094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Galván Casas C, Català A, Carretero Hernandez G, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020;183:71–7. doi: 10.1111/bjd.19163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Zitek T. The appropriate use of testing for COVID-19. West J Emerg Med. 2020;21:470–2. doi: 10.5811/westjem.2020.4.47370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1–13. doi: 10.1016/j.trsl.2020.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]